GenMark Diagnostics, Inc. (GNMK) [Rocket]

Date Filed	Type	Description
03/18/2021	GN	STOCK ALERT: Halper Sadeh LLP Investigates RMBL, STAY, GNMK, TPCO; Shareholders Are Encouraged to Contact the Firm
03/15/2021	GN	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout
03/15/2021	GN	GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.
02/22/2021	GN	GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
02/16/2021	GN	GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference
02/11/2021	GN	GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
01/11/2021	GN	GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
12/28/2020	GN	GenMark Diagnostics to Participate in Upcoming Investor Conferences
10/14/2020	GN	GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020
10/08/2020	GN	GenMark Diagnostics' ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA
10/08/2020	GN	GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020
09/15/2020	GN	Le Panel de pathogènes respiratoires 2 (RP2) ePlex de GenMark Diagnostics obtient le marquage CE
09/14/2020	GN	GenMark Diagnostics' ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
08/17/2020	GN	GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
08/04/2020	GN	GenMark Diagnostics Reports Second Quarter 2020 Results
07/29/2020	GN	GenMark Diagnostics to Participate in Upcoming Investor Conferences
07/21/2020	GN	GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
07/07/2020	GN	GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
06/29/2020	GN	GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
05/27/2020	GN	GenMark Diagnostics to Participate in Upcoming Investor Conferences
05/06/2020	GN	GenMark Prices Public Offering of Common Stock
04/22/2020	GN	GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020
04/07/2020	GN	GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance